GenomicTales retweeted
NEW: @UKHSA Variant Technical Briefing
Technical Briefing 33
assets.publishing.service.go…
Updated Omicron Risk Assessment
assets.publishing.service.go…
GenomicTales retweeted
An update from our team on the latest vaccine effectiveness (VE) estimates against symptomatic infection with the Omicron variant has now been published in the UKHSA Variant Technical Briefing 33 (page 24).
assets.publishing.service.go…
1/9
Genomictales is participating to a workshop on genomics, bioinformatics and proteomics. This course is addressed to medical and health professionals and researchers from different areas
Free registration at crg.eu/en/event/basics-omics…
We are hiring a motivated and enthusiastic bioinformatician.
Follow the link for more information.⬇️
genomictales.com/job-offer/
GenomicTales retweeted
Estudi mot interessant del @copedicat, quines seran les transmissions per les diferents franges edat? Estiguem atents 👀
👇🏼👇🏼👇🏼
Infants i adolescents contagien molt poc el coronavirus, segons confirma un nou estudi ccma.cat/324/infants-i-adole…
GenomicTales retweeted
COVID-19 vaccine.
Hard decision: how to chose the good one among 90 candidates? 🤔
nature.com/articles/d41586-0…
Avui he estat col.laborant per la campanya dels tests massius d’IgG-IgM. Però sabeu per què els analitzem? Elsx IgM són els primers anticossos que genera el sistema immunitari per combatre el Virus. Els IgG són els anticossos que ens protegeixen en front d’una nova infecció








